ANEB - Anebulo Pharmaceutic...

Financial Statements(Q) of Anebulo Pharmaceuticals, Inc.(ANEB), Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and com

Anebulo Pharmaceuticals, Inc.

ANEB

NASDAQ

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.

2.96 USD

0.05 (1.69%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

All Income Statement Balance Sheet Statement Cash Flow Statement Retained Earning Schedule PPE Schedule Intangible and Goodwill Schedule

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.